AAAAAA

   
Results: 1-16 |
Results: 16
LONG-DURATION OF RESPONSE WITH LETROZOLE 2.5 MG (FEMARA(R)) IN 2 TRIALS IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER AFTER ANTIESTROGEN THERAPY
Authors: GARDIN G FORNASIERO A ROMIEU G BUZZI F CHAUDRI HA LASSUS M
Citation: G. Gardin et al., LONG-DURATION OF RESPONSE WITH LETROZOLE 2.5 MG (FEMARA(R)) IN 2 TRIALS IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER AFTER ANTIESTROGEN THERAPY, European journal of cancer, 34, 1998, pp. 46-46
PRIMARY CHEMOTHERAPY IN LOCALLY ADVANCED BREAST-CANCER (LABC) - EFFECTS ON TUMOR PROLIFERATIVE ACTIVITY, BCL-2 EXPRESSION AND THE RELATIONSHIP BETWEEN TUMOR-REGRESSION AND BIOLOGICAL MARKERS
Authors: COLLECCHI P BALDINI E GIANNESSI P NACCARATO AG PASSONI A GARDIN G RONCELLA M EVANGELISTA G BEVILACQUA G CONTE PF
Citation: P. Collecchi et al., PRIMARY CHEMOTHERAPY IN LOCALLY ADVANCED BREAST-CANCER (LABC) - EFFECTS ON TUMOR PROLIFERATIVE ACTIVITY, BCL-2 EXPRESSION AND THE RELATIONSHIP BETWEEN TUMOR-REGRESSION AND BIOLOGICAL MARKERS, European journal of cancer, 34(11), 1998, pp. 1701-1704
LOCALLY ADVANCED BREAST-CANCER (LABC) - PROGNOSTIC VARIABLES AFFECTING RESULTS
Authors: BALDINI E GARDIN G LIONETTO R MONTANARO E SALVADORI B MASSA R ROSSO R CONTE PF
Citation: E. Baldini et al., LOCALLY ADVANCED BREAST-CANCER (LABC) - PROGNOSTIC VARIABLES AFFECTING RESULTS, European journal of cancer, 34, 1998, pp. 47-47
LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE
Authors: DOMBERNOWSKY P SMITH I FALKSON G LEONARD R PANASCI L BELLMUNT J BEZWODA W GARDIN G GUDGEON A MORGAN M FORNASIERO A HOFFMANN W MICHEL J HATSCHEK T TJABBES T CHAUDRI HA HORNBERGER U TRUNET PF
Citation: P. Dombernowsky et al., LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE, Journal of clinical oncology, 16(2), 1998, pp. 453-461
A RANDOMIZED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN LOCALLY ADVANCED BREAST-CANCER
Authors: BALDINI E GARDIN G GIANNESSI P BREMA F CAMORRIANO A CARNINO F NASO C PASTORINO G PRONZATO P ROSSO R RUBAGOTTI A TORRETTA G CONTE PF
Citation: E. Baldini et al., A RANDOMIZED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN LOCALLY ADVANCED BREAST-CANCER, Tumori, 83(5), 1997, pp. 829-833
VINORELBINE AS PALLIATIVE THERAPY IN ADVANCED BREAST-CANCER
Authors: GASCO M GARDIN G REPETTO L CAMPORA E ROSSO R
Citation: M. Gasco et al., VINORELBINE AS PALLIATIVE THERAPY IN ADVANCED BREAST-CANCER, Anticancer research, 17(2B), 1997, pp. 1431-1433
LONIDAMINE PLUS EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: GARDIN G BARONE C NASCIMBEN O IANNIELLO G STURBA F CONTU A PRONZATO P ROSSO R
Citation: G. Gardin et al., LONIDAMINE PLUS EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of cancer, 32A(1), 1996, pp. 176-177
CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL OF THE GRUPPO-ONCOLOGICO-NORD-OVEST (GONO)
Authors: CONTE PF BALDINI E GARDIN G PRONZATO P AMADORI D CARNINO F MONZEGLIO C GENTILINI P GALLOTTI P DEMICHELI R VENTURINI M RUBAGOTTI A ROSSO R
Citation: Pf. Conte et al., CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL OF THE GRUPPO-ONCOLOGICO-NORD-OVEST (GONO), Annals of oncology, 7(5), 1996, pp. 487-490
LOCALLY ADVANCED NONMETASTATIC BREAST-CANCER - ANALYSIS OF PROGNOSTICFACTORS IN 125 PATIENTS HOMOGENEOUSLY TREATED WITH A COMBINED-MODALITY APPROACH
Authors: GARDIN G ROSSO R CAMPORA E REPETTO L NASO C CANAVESE G CATTURICH A CORVO R GUENZI M PRONZATO P BALDINI E CONTE PF
Citation: G. Gardin et al., LOCALLY ADVANCED NONMETASTATIC BREAST-CANCER - ANALYSIS OF PROGNOSTICFACTORS IN 125 PATIENTS HOMOGENEOUSLY TREATED WITH A COMBINED-MODALITY APPROACH, European journal of cancer, 31A(9), 1995, pp. 1428-1433
BREAST-CANCER IN THE ELDERLY - DETECTION AND TREATMENT MODALITIES IN 341 WOMEN
Authors: REPETTO L MIGLIETTA L COSTANTINI M QUEIROLO P CANNATA D PACE M GARDIN G GUIDO T AMOROSO D CAMPORA E BOCCARDO F ROSSO R
Citation: L. Repetto et al., BREAST-CANCER IN THE ELDERLY - DETECTION AND TREATMENT MODALITIES IN 341 WOMEN, International journal of oncology, 5(6), 1994, pp. 1399-1403
IN-VIVO CYTOKINETIC EFFECTS OF RECOMBINANT HUMAN GROWTH-HORMONE (RHGH) IN PATIENTS WITH ADVANCED BREAST-CARCINOMA
Authors: BALDINI E GIANNESSI PG GARDIN G ALAMA A MINUTO F BARRECA A CONTE PF
Citation: E. Baldini et al., IN-VIVO CYTOKINETIC EFFECTS OF RECOMBINANT HUMAN GROWTH-HORMONE (RHGH) IN PATIENTS WITH ADVANCED BREAST-CARCINOMA, Journal of biological regulators and homeostatic agents, 8(4), 1994, pp. 113-116
RELATIONSHIP OF VARIATIONS IN TUMOR-CELL KINETICS INDUCED BY PRIMARY CHEMOTHERAPY TO TUMOR-REGRESSION AND PROGNOSIS IN LOCALLY ADVANCED BREAST-CANCER
Authors: GARDIN G ALAMA A ROSSO R CAMPORA E REPETTO L PRONZATO P MERLINI L NASO C CAMORIANO A MEAZZA R BARBIERI F BALDINI E GIANNESSI PG CONTE PF
Citation: G. Gardin et al., RELATIONSHIP OF VARIATIONS IN TUMOR-CELL KINETICS INDUCED BY PRIMARY CHEMOTHERAPY TO TUMOR-REGRESSION AND PROGNOSIS IN LOCALLY ADVANCED BREAST-CANCER, Breast cancer research and treatment, 32(3), 1994, pp. 311-318
PHASE-II STUDY OF WEEKLY MITOXANTRONE, 5-FLUOROURACIL, AND LEUCOVORININ METASTATIC BREAST-CANCER
Authors: REPETTO L MIGLIETTA L GARDIN G LANFRANCO C NASO C MERLINI L GIUDICI S VENTURINO A CAMPORA E TESTORE F ROSSO R
Citation: L. Repetto et al., PHASE-II STUDY OF WEEKLY MITOXANTRONE, 5-FLUOROURACIL, AND LEUCOVORININ METASTATIC BREAST-CANCER, Breast cancer research and treatment, 30(2), 1994, pp. 133-137
LYMPHOBLASTOID INTERFERON IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: NASO C SIMONI C MERLINI L ROSSO M PRONZATO P REPETTO L GARDIN G ROSSO R
Citation: C. Naso et al., LYMPHOBLASTOID INTERFERON IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, Journal of chemotherapy, 5(4), 1993, pp. 258-261
SERUM CEA, CA 15-3, AND MCA IN BREAST-CANCER PATIENTS - A CLINICAL-EVALUATION
Authors: REPETTO L ONETTO M GARDIN G COSTANZI B GIUDICI S VITIELLO E MERLINI L NASO C ZANNINI C PAGANUZZI M ROSSO R SANTI L
Citation: L. Repetto et al., SERUM CEA, CA 15-3, AND MCA IN BREAST-CANCER PATIENTS - A CLINICAL-EVALUATION, Cancer detection and prevention, 17(3), 1993, pp. 411-415
ANALYSIS OF TIME TO RESPONSE TO CHEMOTHERAPY IN 316 METASTATIC BREAST-CANCER PATIENTS
Authors: PRONZATO P BERTELLI G GARDIN G RUBAGOTTI A CONTE PF ROSSO R
Citation: P. Pronzato et al., ANALYSIS OF TIME TO RESPONSE TO CHEMOTHERAPY IN 316 METASTATIC BREAST-CANCER PATIENTS, Oncology, 50(6), 1993, pp. 460-465
Risultati: 1-16 |